WeedVoice

An online media news aggregator and blog for the cannabis and hemp industry world-wide.

The Politics of Marijuana

Marijuana has been considered to be quite taboo throughout time. With prohibition in the U.S. being in place since the early 1900s based on a large amount of propagandistic anti-cannabis campaigns. Since then, the world of cannabis has been on the fritz.

The last ten years have seen a dramatic shift in the public opinion of cannabis. With many states choosing to legalize the substance for use recreationally and medicinally, cannabis has never been so widely accepted. Some studies have shown that in the U.S., as much as 70% of the population is in favor of cannabis, but this has been a difficult number for the federal government to rap its head around.

For some time, the use of cannabis has also had a large impact on racial relations within the U.S. as well. Many have claimed that cannabis’ legal standing throughout the country has been used to racially profile and jail innocent individuals. There are many large social issues that have come into play in the world of cannabis, which continue to effect the outcome of legislation up until this day. The changing public opinion is the most important step toward changing the future of the cannabis world. As individuals become more comfortable with the idea of legislation, the hopes are that many of the social and political issues we have encountered in the world of pot will slowly begin to dissipate.

With the industry on marijuana booming into the billions, politics and the ramifications of various policies will continue to be the most difficult part of the industry. The hopes are high that the not too distant future will be filled heavily with the support of cannabis as it currently stands today. Only time will tell what these effects have on the future of the U.S. and relations from the federal government to the individual level.

 

Continue reading
0 Comments

Lets Not Forget About Marijuana’s Positive Contributions To The World Of Medicine

Some politicians and those who oppose the legalization of marijuana choose not to recognize all the good it can do. Instead, they try and hurl insults at the drug with the goal of influencing others to agree with them. But science doesn’t lie and previous studies don’t seem accurate considering all the health benefits marijuana has to offer the medical world today.

These kinds of people always claimed that marijuana had huge effects on the developing brains of children, but recent studies show different. Marijuana seems to not have an immense effect on brains as we once previously believed. In past studies, doctors concluded that people who use marijuana will experience difficulty learning, remembering, and focusing. They believed that they would have a harder time conceptualizing ideas in comparison with people who didn’t smoke marijuana. Doctors believed that people smoking marijuana would experience short and long-term effects. Doctors tended to focus on the executive functioning skills and how those would be affected. Regardless, recent studies show how that information may have been an exaggeration, and that this will probably entice people to believe in the legalization of marijuana. It is getting more and more difficult for people to find wrong with marijuana, and therefore they won’t be able to deprive people of something if it really has no harmful effects.

Aside from the lack of harmful effects, it is important to pay attention to all of marijuana’s positive uses. A drug manufacturer called GW Pharmaceuticals recently opened up about its breakthrough treatment for epilepsy. The drug is called Epidolex and it contains CBD which is a non-psychoactive constituent of the cannabis plant. The company has been demonstrating the effectiveness of the drug and the FDA issued a report about the new drug saying that it had “substantial evidence”. People are starting to use, accept, and profit from marijuana’s magical uses. Dravet and Lennox-Gastaut are different types of epilepsy that tend to impact children. Statistics show that more than 1 out of every 4 kids with Dravet die before they become adults. This new drug can be the answer to these kid’s illnesses because the CBD in the drug doesn’t get its users high. The chances that the drug gets approved by the FDA is very high and it will give the children suffering from this syndrome the help and hope that they need.

Many of the drugs that are being sold to people that are over the counter are much more addictive and dangerous than marijuana. This is also why we have been able to notice a relationship between increasing marijuana legalization and the decrease for opioid drugs. Opioid drugs are a major issue for the United States, and so finding a safer substitute was a miracle. Many other nations realize the positive effects of marijuana and they have decided to dedicate more time and research toward the drug. Instead of avoiding all the good marijuana can do, many places have deiced to embrace it. Places like Spain, Canada, Czech Republic, Uruguay, Netherlands, and Israel have all put money and effort into seeing how cannabis can help their people.

The post Lets Not Forget About Marijuana’s Positive Contributions To The World Of Medicine appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

What’s Happening in The World Of Cannabis?

A lot has happened in the world of cannabis over the course of the past several weeks. From positive steps toward legislation nationwide to new products seeing approval by the FDA, it is undoubtedly an exciting time for marijuana.

For the past 80 years or so, cannabis has been considered a Schedule I narcotic as far as the national government is concerned. This essentially means that they believe cannabis has no potential for treating illnesses as while as a high rate of addiction. Both of these statements have been disproven many times with modern science and research, thus the need for new legislation. Broader acceptance of the plants use has been happening across the nation with states choosing to legalize their own cannabis industries whether it be for recreational or medicinal use.

The current state of cannabis in this country has seen difficult standpoints from those in government such as Attorney General Jeff Sessions. With the war on drugs still in full swing, it has been difficult to try and reach new middle grounds in the world of cannabis. Jeff Sessions has been working to undo years of progress in the industry, but recent news has shown that the president may be committed to ensuring states have their own right to enforce legal cannabis laws.

Several states have pledged that they may be introducing cannabis into the ballot for this upcoming year such as Michigan, Missouri, and possibly Utah. Many states are choosing to legalize cannabis due to the fact that it creates new jobs, high tax revenue, and has a large amount of potential to help people with a wide variety of diseases.

It is becoming increasingly difficult to attempt to discredit the marijuana industry as many world leaders have been trying to do. With a massive amount of research showing large potential for marijuana to treat or even cure diseases such as cancer, Alzheimer’s and more, there is no way to discredit cannabis as a medicine. With new work being done by a large amount of those in government to attempt to legalize cannabis nationwide, it seems as though the future of marijuana is still very bright.

Continue reading
0 Comments

Marijuana Stocks – Happy 4/20!

Good Morning & Happy Friday! – 4/20/2018!

Is Leafbuyer (LBUY) Setting Up For Another Move? Over the last few weeks we’ve seen a similar trend from LBUY that we saw late last year with a multi-day move up that began on March 29. There was a slight pullback around April 9th and then a new volume surge that seems to have triggered a big move. But a recent consolidation & sideways trend could be open opportunity to see what comes next on the overall uptrend that LBUY has been showing. Are new highs coming on the most “sacred day” for the MJ Industry?See For Yourself

The History of 4/204/20 is widely regarded as a sacred number in the world of cannabis. For quite some time, 4/20 has been considered a holiday in the world of weed, but where did it get its origins?Read The Full Article Here

Is the Senate Coming Closer to Ending Cannabis Prohibition?The most recent news in the world of cannabis has shown that Congress could potentially be working to legalize the use of cannabis nationwide. One of Congress’s most vocal personnel against the use of drugs has now stated that he would like to begin the process of Ending federal cannabis prohibition.Read The Full Article Here

 Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

Continue reading
0 Comments

mCig, Inc. (MCIG) Subsidiary, Grow Contractors Inc., Announces it has Secured an Exclusive Management Contract

mCig’s Subsidiary, Grow Contractors Inc., Announces it has Secured an Exclusive Management Contract in Sacramento, CA, Paving the Way to an Expanded Presence in the StatemCig, Inc. (MCIG) www.mciggroup.com, a diversified company servicing the legal cannabis markets, announced today that its subsidiary Grow Contractors (GC) has secured a minimum 3 year exclusive management contract with a client in Sacramento, CA. The project is currently underway and is approximately 50% completed. The GC team helped the client to secure all the necessary construction permits as well as the competitive city licenses.

GC has provided consulting, engineering and design work for the production and extraction facility, which is projected to generate between 10 to 12 million a year, with 10 percent of net profits going to Grow Contractors monthly. The cultivation side will feature advanced lighting from Asgard Concepts, the Thor 1000W HPS, as well as two complete extraction lines for ethanol. It will also have automated filling and packaging machinery. This contract alone has already generated 200k in revenues for the company this current financial quarter.

“This facility is the third in our plan to create a network of manufacturers and cultivators that are able to produce better product at a more competitive price,” commented Rob Kressa, CEO of Grow Contractors Inc. “We are incredibly busy getting our clients online, but the end result will be an unstoppable group of extraction labs and cultivators that are united in creating products such as distillate and other extracts. The facilities will be able to complement each other and work together when it comes to filling large orders in the California recreational market. We will mostly focus on white-labeling products for other brands, but there are plans to create proprietary brands which will have lasting market value through GC. Be prepared for more announcements regarding innovative and hip California brands.”

About MCIG Group (MCIG)

Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. is committed to be the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry.

For more information visit our websites:

Continue reading
0 Comments

Is the Senate Coming Closer to Ending Cannabis Prohibition?

The most recent news in the world of cannabis has shown that Congress could potentially be working to legalize the use of cannabis nationwide. One of Congress’s most vocal personnel against the use of drugs has now stated that he would like to begin the process of ending federal cannabis prohibition.

The Congressman is Senate Minority Leader Chuck Schumer of New York. Schumer announced on Thursday, 4/19 that he would bring a bill to light that would remove the substance from the Controlled Substances Act altogether. This would be a huge step in the fight for fair marijuana legislation as no one has come this close in the past. The issue that currently stands is that cannabis is scheduled as a Schedule I narcotic as far as the federal government is concerned. This means that the drug has no potential for medicinal use as well as a high rate of addiction. Both of these claims have heavily been refuted by various scientists and research studies, thus the continuous need to end this unfair legislation.

Schumer stated recently in an interview that “the legislation is long overdue. I’ve seen too many people’s lives ruined because they had small amounts of marijuana and served time in jail much too long.” The news comes at the same time that Sen. Bernie Sander of Vermont has joined several other Democratic candidates to sponsor even more liberal marijuana policy.

The bill that they would like to be put in place is known as the Marijuana Justice Act. This act would completely remove the substance from the Controlled Substances Act, and it would also help to withhold funding from states that have been notorious in racially profiling marijuana enforcement.

Justin Strekal, political director of NORML stated that “with this announcement, Senator Schumer has effectively made it clear that a legislative priority for the Democratic Party is to end the federal prohibition of marijuana. As Democratic Leader, it is his role to ensure that the caucus as a whole falls in line with this public policy position — a position that is held by more than 60% of Americans.” The bill would also according to one study “create some funding for minority and women-owned marijuana businesses, provide money for research into overall effects of marijuana and its specific effect on driving impairment.”

Continue reading
0 Comments

The History of 4/20

4/20 is widely regarded as a sacred number in the world of cannabis. For quite some time, 4/20 has been considered a holiday in the world of weed, but where did it get its origins?

Around the world, April 20th is considered to be a holiday for weed with celebrations happening all over the place. The holiday ends usually at 4:20 pm, when everyone smokes together at once. Many people are unsure of the origins of this holiday, and they are still a little hazy.

Back in the early 60s in Northern California, legends say that kids ended school at 4:20 in the afternoon. After they got out of school, they would go and toke up rightfully so. They are said to be the unofficial masters of the holiday of smoke. One of the pioneers of the time, David Reddix, a filmmaker and CNN cameraman stated that “we thought it was a joke then, we still do.”

Reddix along with several other buddies formed a click back during the 60s that would become the breeding ground for smoking on the northern coast. This origin though has been quite obscured throughout time with no one really knowing whether or not this is the true nature of the term 4/20.

Other stories state that the origins started with the Grateful Dead back in Oakland in the 90s. The hippies going to the concert would always meet before at the sacred time, right at the Marin County Bolinas Ridge sunset spot. Flyers used to be passed around with this time and meeting spot on it, helping to show a possible origin for the time and date. The flyer stated “420 started somewhere in San Rafael, California in the late ‘70s. It started as the police code for Marijuana Smoking in Progress. After local heads heard of the police call, they started using the expression 420 when referring to herb – Let’s Go 420, dude!”

Continue reading
0 Comments

Marijuana Stocks Mid Morning Update! – April 19, 2018

Relevium Technologies Inc. (RLLVF) CREATES BIOCANNABIX SUBSIDIARY AND TARGETS LEGAL CANNABIS BUSINESS Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the creation of Biocannabix Health Corporation (the “Subsidiary” or “BHC”), a Canadian wholly owned subsidiary structured to lead the development of the legal cannabis derivatives business for RLV. The Company projects to complete its ACMPR application for the Canadian marketplace within the current fiscal quarter and has begun to assemble its legal and regulatory team of experts within targeted jurisdictions.See For Yourself

One Marijuana Stock Taking CBD To The Next LevelIn an era of increased focus on health and wellness and online sales, One Company could be sitting in a perfect position.Read The Full Article Here

What Is The Current Progression With Marijuana Legislation?The legal marijuana industry has largely been dependent on the progression of new laws over the past few decades. With states taking on the power to create laws in favor of cannabis legalization, it seems as though a new era of legislation has dawned upon us. Legislative measures are continuing to happen throughout the nation at record speed, and the future of the weed industry is following suit.Read The Full Article Here

Pursuant to an agreement between Relevium Technologies Inc (RLV), we were hired for a period of 3 months from 4/10/2018 – 7/15/2018 to publicly disseminate information about (RLV) including on the Website and other media including Facebook and Twitter. We are being paid $90,000 (CASH) for or “350,000” shares of restricted or unrestricted common shares. We own zero shares of (RLV) which we purchased in the open market.We may buy or sell additional shares of (RLV) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

The post Marijuana Stocks Mid Morning Update! – April 19, 2018 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

One Marijuana Stock Taking CBD To The Next Level

In an era of increased focus on health and wellness and online sales, Relevium Technologies (TSXV:RLV) (OTC:RLLVF) could be sitting in a perfect position. Through its acquisition of Bioganix and Joint Venture with Hempco for the distribution of its PlanetHemp product line, the company is poised to capture market share in the extremely fast growing hemp and hemp-based derivative market.

Through their successful e-commerce platform and distribution through Amazon, the company has already generated CAD $2.1M in revenue with a gross profit of CAD $1,231,020 (58% gross margin). This has resulted in Relevium already achieving a record month in March for a total of 16,549 units. The recorded units sold for the month of March is anticipated to translate in sales of over CAD $439,000!

Credit – Marijuana Stocks

With an expertise in online sales and the recent launch of the company’s partnership with Aurora Cannabis backed HempCo products, Relevium is poised to capitalize on the hemp and hemp-based derivative market. Relevium and its cannabis based brands could do quite well in America especially with the Federal government’s recent Hemp Farming Act just introduced. On April 5, 2018 , the company announced it will be expanding its operations to the European market and will include 8 of the company’s best-selling products, mainly through its Amazon channel. These sales are expected to launch during the week of May 21st 2018 and could provide an interesting geographical expansion for hemp products

Furthermore, investors should take notice of a recent appointment of Relevium’s CEO. On Monday April 16, 2018, Linage Grow (CSE: BUDD) announced that Aurelio Useche, CEO of Relevium Technologies, was appointed to Chairman of the Board. This is a very interesting dot to connect with Relevium as Lineage Grow has a seasoned executive team that has been involved with large cannabis companies such as Canopy Growth Corp (TSX: WEED), Tinley (CSE: TNY) (OTC: TNYBF) and Nutritional High (CSE: EAT) (OTC: SPLIF) just to name a few.

Moreover, the company stated in the H2 Guidance on March 2nd 2018 that “Relevium has seen an increase in online content and traffic for hemp and hemp derivatives such as CBD. The market place is changing fast and the rate of adoption as well. In advance of fully launching products, brands and new business segments, the Company has begun accumulating a portfolio of domain names and is also building online assets for an elevated an trusted brand in the space.”

Continue reading
0 Comments

Relevium Technologies Inc. (RLLVF) CREATES BIOCANNABIX SUBSIDIARY AND TARGETS LEGAL CANNABIS BUSINESS   

RELEVIUM CREATES BIOCANNABIX SUBSIDIARY AND TARGETS LEGAL CANNABIS BUSINESS

Relevium Technologies Inc. (TSX.V:  “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the creation of Biocannabix Health Corporation (the “Subsidiary” or “BHC”), a Canadian wholly owned subsidiary structured to lead the development of the legal cannabis derivatives business for RLV. The Company projects to complete its ACMPR application for the Canadian marketplace within the current fiscal quarter and has begun to assemble its legal and regulatory team of experts within targeted jurisdictions.

Highlights

Biocannabix Health Corporation to lead the Company’s legal cannabis initiativesFocus on developing a portfolio of high end consumer brands for North AmericaPrepare for a global online marketplace for jurisdictions with a legal contextSubsidiary anticipates applying for the necessary ACMPR licenses from Health CanadaInitial commercial focus will be on industrial hemp derivatives such as CBG and CBD

As a Canadian company, Relevium  will initially target the legal cannabinoids markets in North-America and develop medical, lifestyle and luxury consumer products aimed at supporting overall health and wellness. The Company’s newly created subsidiary is expected to begin the process of obtaining access to cannabis for medical purposes through the filing of an application for the appropriate licences from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR).  The primary purpose of the application will be to enable the Company, through Biocannabix, to secure the appropriate legal authorizations to be able to distribute and sell medical cannabis products in Canada and service other jurisdictions in the export market.

Aurelio Useche, CEO of  Relevium stated: “Our core business is health and wellness and the legal Cannabis derivative business is growing exponentially in our niche. In the US, relaxing regulations and a fragmented market place represent a true opportunity to build elevated and trusted cannabinoid derivative consumer brands”. Mr. Useche continued: “In the industrial hemp derivatives space there is rapid proliferation of cannabinoids-based products like CBG and CBD. The challenge, however, is Branding, Quality and Customer Experience, all areas that RLV intends to leverage through its channel expertise.”

Continue reading
0 Comments

Marijuana Stocks – Good Morning & Happy Thursday! – April 19, 2018

Good Morning & Happy Thursday! – 4/19/2018!

Is Leafbuyer (LBUY) Setting Up For Another Move? Ever since picking back up on LeafBuyer (LBUY), we’ve seen this do something it hasn’t done since December & the big news from last week (more below) could have a lasting impact heading into this week. In mid December, LBUY climbed for several days, saw a brief pull-back and then ran as high as $3.15. Over the last few week we’ve seen a similar trend of a multi-day move up starting on March 29, a slight pullback around April 9th and then a new volume surge that seems to have triggered a monster breakout over the last 10 days. But a recent pull-back could be open opportunity to see what comes next on the overall uptrend that LBUY has been showing. Are new highs coming soon?See For Yourself

Is Cannabis Prohibition on Its Way Out?The world of cannabis has been extremely lucrative over the past several years, but the issue of legislation in favor of the substance continues to be a widely argued over matter. A new bill being crafted by the Colorado Senator, Cory Gardner, could potentially change the way that the federal government interacts with states who have legalized cannabis. With reassurances from the President and several sponsors on the bill, it seems as though cannabis prohibition could potentially be on its way out.Read The Full Article Here

Hemp Farming is Making an Impact in The Marijuana IndustryThe U.S. currently stands as the worlds largest consumer of hemp-based products, but with federal laws prohibiting the growth of hemp internally, we currently import as much as $100 million in hemp products per year. This number could be changing very soon as a new bill has entered the government that could potentially change the way we use hemp in this country.Read The Full Article Here

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
0 Comments

Hemp Farming is Making an Impact in The Marijuana Industry

The U.S. currently stands as the worlds largest consumer of hemp-based products, but with federal laws prohibiting the growth of hemp internally, we currently import as much as $100 million in hemp products per year. This number could be changing very soon as a new bill has entered the government that could potentially change the way we use hemp in this country.

The introduction of the Hemp Farming Act of 2018 by the Senate Majority leader Mitch McConnell, states that hemp would be legalized as an agricultural commodity and would also be removed from the list of controlled substances. This may not seem like a big deal at first, but the potential that can come from this bill is astonishing.

This is not the first time that a bill like this has entered the realm of the Senate, but the majority of the time it has only led to stalling due to the fact that many in government do not see a difference between hemp and cannabis. Because of the new information showing that hemp has a massive amount of potential to create jobs and economic prosperity, the bill could finally see itself passing this time around.

The main issue that goes with hemp is the fact that it is very closely related to its illegal brother, marijuana. Hemp has however been around since the beginning of the country, being grown by many of the founding fathers. Fun fact, hemp was also considered legal tender back in 1631 until the 1800s, for paying taxes.

Back in the late 30s, cannabis was made outlawed as we know it now by the Marijuana Tax Act. Much of this was due to a large amount of propaganda being circled around, but this has been defeated by modern day science to some extent. The hemp plant is extremely different from that of the cannabis plant. For starters, hemp only has trace amounts of the chemical THC, which is what gets you high, and because of that any person using it to get high would have to consume an inhuman amount of the substance. Much of the drug war has been fueled by attempting to fight cannabis and not hemp although hemp has often gotten pushed into the mix.

Continue reading
0 Comments

iMD Companies, Inc. (ICBU) Completes Acquisition of LCG Plastech Private Limited Company in India

iMD Companies, Inc. (ICBU) Completes Acquisition of LCG Plastech Private Limited Company in India

iMD Companies, Inc. (ICBU) Board of Directors announced today that the company has completed the acquisition of LCG Plastech as a wholly owned subsidiary of the company. LCG Plastech is an audited PVC Pipe manufacturing company and owns a manufacturing plant in Orissa, India.  LCG is a great compliment to iMD’s other companies and has revenues in the millions. The company has been an acquisition target of the company for several months due to their PVC pipe product line and contractual partnerships.

Mr. Ranjit Pattnaik, Managing Director of LCG Stated, “We are excited to form this partnership with iMD Companies Inc. We feel that being part of a public company like iMD will give us more exposure and will also give us more visibility for business expansion with the other mining companies that iMD owns. We look forward to working with the iMD team and feel that we can greatly benefit each other in our desire to grow both companies’ revenues and profits.”

About iMD Companies, Inc.  www.imdcompaniesinc.com

IMD Companies, Inc., (ICBU) is a Florida corporation, engaged in the manufacturing, extraction and distribution in mining and asset accumulations of revenue producing companies. The company is positioned to be a holding company for acquisitions in the mining industries. The company and the principals of the management team have extensive backgrounds in finance, manufacturing, marketing and distribution. ICBU’s goal is to create and increase shareholder value by tactically growing our business while strategically seeking to acquire new business and create other business alliances, which generate increased revenues and earnings

Safe Harbor Statement:

Continue reading
0 Comments

Is Cannabis Prohibition on Its Way Out?

The world of cannabis has been extremely lucrative over the past several years, but the issue of legislation in favor of the substance continues to be a widely argued over matter. A new bill being crafted by the Colorado Senator, Cory Gardner, could potentially change the way that the federal government interacts with states who have legalized cannabis. With reassurances from the President and several sponsors on the bill, it seems as though cannabis prohibition could potentially be on its way out.

One of the largest issues in the U.S. market on cannabis is from the Attorney General Jeff Sessions. Sessions has made it very clear that he is a proponent of continuing the failed war on drugs. The government in the U.S. has continued to list the substance as a schedule I narcotic, meaning that from their standpoint, it has no use in the medical industry as well as a high potential for addiction. Both of these points have been heavily refuted in the past, but the government still stands by their opinion. Many studies have shown that cannabis is a viable treatment for a broad range of diseases, notably cancer, pain management, seizures and more.

Interestingly, a large amount of research has been done into seeing how cannabis could potentially treat opioid addiction and even bring the current crisis we are in with opioid use to an end. Researchers reported recently that cannabidiol in cannabis “interferes with brain reward mechanisms responsible for the expression of the acute reinforcing properties of opioids.” This means that cannabis could potentially block the effects of opioid use that makes it addicting in the first place.

All of these pieces of news are coming together to help paint a solid narrative as to why cannabis should be legalized. This is the point that Senator Gardner is attempting to make, which has been met quite positively in recent news.

The current state of cannabis in the U.S. has been extremely confusing to those involved. With the federal government working to fight against states efforts to individually legalize the substance, the battle has continued to be ongoing. Many states who have chosen to legalize cannabis have seen their tax revenues skyrocket, as well as a large amount of positivity coming from their constituents. All of these together should be a clear enough picture for the government to recognize, but nothing has officially happened at this point in time.

Continue reading
0 Comments

Hemp, Inc. (HEMP) Announces CEO Bruce Perlowin as Speaker on First-Ever Hemp Panels at Black Communities Conference in North Carolina

Hemp, Inc. Announces CEO Bruce Perlowin as Speaker on First-Ever Hemp Panels at Black Communities Conference in North Carolina

Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with the largest multipurpose industrial hemp processing facility in the western hemisphere, announced today that the Company’s CEO Bruce Perlowin will be speaking at the Black Communities Conference on Monday, April 23, 2018 at the Carolina Theatre in Durham, North Carolina  and at the afternoon workshop at the NC Biotechnology Center in the Research Triangle Park. He will join other industry experts on three of the event’s first-ever hemp panels, discussing the business of hemp, the overall industry and plant genetics.

“We are honored to participate in the first-ever hemp panels and to guide this new conversation topic at the conference,” said Hemp, Inc. CEO Bruce Perlowin. “The state of North Carolina is quickly becoming the center of the industrial hemp industry and we are excited to be a part of its growth both on a regional and national level.”

Conference organizers created discussion opportunities about industrial hemp at this year’s event due to increased demand for hemp education from local farmers. Hemp, Inc. wholly-owned subsidiary Hemp University, LLC offers industrial hemp educational programs for farmers in North Carolina throughout the year, making Perlowin’s participation in this high-in-demand event a natural fit. The hemp industry is projected to grow 700% and hit $1.8 billion by 2020, according to Hemp Business Journal. Perlowin’s complete speaking schedule at the conference can be found below.

11:00 a.m. – The Hemp Industry: Avoiding Pitfalls

Continue reading
0 Comments

INSYS Therapeutics, Inc. (INSY) to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device

INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device

INSYS Therapeutics, Inc. (INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced plans to advance clinical research of dronabinol inhalation using a novel and patented breath-actuated device—licensed from U.K.-based Senzer Ltd. and accepted by the U.S. Food and Drug Administration (FDA) under an investigational new drug (IND) filing—in the second half of 2018.

“Senzer’s proprietary inhalation technology involves no heat or combustion to deliver the therapeutic molecule to the distal lung, an important attribute in connection with dronabinol, which requires an ambient temperature to maintain molecular stability,” explained Venkat Goskonda, senior vice president of R&D for INSYS Therapeutics. “Our partner’s hand-held device is actuated by the user’s inhalation, obviating the need for the hand-breath coordination that is required with traditional metered-dose inhalers.”

Senzer’s chief executive officer, Alex Hearn, added: “We are excited to be supporting INSYS on its clinical development program for dronabinol inhalation. The device we have licensed to INSYS is a unique inhalation system—distinct from a nebulizer—because it does not require a battery or a heating element to operate. Importantly as well, the technology inside the device has already been approved by the U.K.’s Medicines and Healthcare products Regulatory Agency, the MHRA.”

Ultimately, INSYS intends to study dronabinol inhalation as an investigational treatment for anorexia in cancer and agitation in Alzheimer’s disease. Currently planned studies target anorexia associated with weight loss in patients with AIDS and chemotherapy-induced nausea and vomiting in adult cancer patients whose response to conventional antiemetics is inadequate.

INSYS’s cannabinoids platform also includes cannabidiol (CBD) oral solution, with clinical trials for infantile spasm, childhood absence epilepsy and Prader-Willi syndrome.

Continue reading
0 Comments

Lifestyle Delivery Systems Inc. (LDSYF) announces Update on Trade Marks and Patent

Lifestyle Delivery Systems Inc. announces Update on Trade Marks and Patent

Lifestyle Delivery Systems Inc. (LDS.CN), (LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces updates on trade mark filings and scheduling of clinical trials for bio-availability of CannaStripsTM.

The CannaStripsTM Logo and tag line Smoke Free Pain Relief have been issued European Union trade mark registration numbers 017383712 and 017383738 by the European Union Intellectual Property Office. The Company has also applied for California Trademark protection.  These marks are in addition to the Canadian Trademarks currently held by the Company.

The Company is scheduling clinical trials in May 2018 to define the bio-availability benefits of the Lifestyle Delivery Systems’ CannaStripsTM technology. These clinical trials are intended to quantify the enhanced delivery method of CannaStripsTM vs other forms of delivery.

Recent inquiries regarding the CTT Pharmaceutical Holdings, Inc. (“CTT Pharma”) claims regarding a new patent for oral delivery has forced the Company to share the findings from three independent Patent Lawyers on both sides of the US/Canadian border. First and most important, the technology described in the CTT Pharma patent does not resemble the CannaStripsTM patent and LDS believes there is no infringement by either patent of the other. Secondly, a nearly identical CTT Pharma patent was filed in the United States over twenty years ago and expired over two years ago, which means that patent has no force or effect in the United States. That patent did not preclude a number of pharmaceutical companies from producing oral film products, such as breath strips or thera-flu strips, for the last twenty years in either the United States or Canada. Additionally, no commercialized version of the specific CTT patent in the United Statesduring its twenty-year history was found. We are continuing to research the CTT Pharma patent and will update our shareholders upon any further relevant information should it become available. LDS CEO Brad Eckenweiler stated, “We are confident that the CannaStripsTM technology is not infringed on by the CTT Pharma patent and that the clinical trials scheduled in May will add additional separation from other methods of delivery, both old and new.”

About Lifestyle Delivery Systems Inc.

Continue reading
0 Comments

Marijuana Stocks Newsletter – Good Morning & Happy Wednesday! – April 18, 2018

Good Morning & Happy Wednesday! – 4/18/2018!

What’s Next For Leafbuyer (LBUY)? Over the last few week we’ve been watching LBUY make a move of roughly 50% since reinitiating coverage on this company. The new partnership with DOPE Media, a highly-respected media veteran in the legal cannabis industry now has the company aiming to expand the reach of Leafbuyer’s deals platform to millions of new cannabis users across North America. And with the added attention from the market, which has stemmed from two key developments with the US government, it has us wondering what is next for LBUY and other marijuana stocks in the market.See For Yourself

Senate Works to Legalize Industrial Hemp NationwideA new piece of legislation that would allow hemp to be legalized as an agricultural product is making its way through the Senate right now.

The bill was introduced to the Senate last week by the majority leader Mitch McConnell. After the bill was introduced, something known as Rule 14 was put in place. This rule is a procedural move that effectively allows a bill to skip over the committee process so that it can quickly be brought to the Senate floor.Read The Full Article Here

New Cannabis-Based Drug Backed By The FDA?A new medicine that many are still considering to be in its experimental stages could potentially be the first drug made from the cannabis plant that would receive a boost from the Food and Drug Administration staff.

Continue reading
0 Comments

New Cannabis-Based Drug Backed By The FDA

A new medicine that many are still considering to be in its experimental stages could potentially be the first drug made from the cannabis plant that would receive a boost from the Food and Drug Administration staff.

The drug has been created and manufactured by the U.K. company GW Pharmaceuticals, one of the big players in the cannabis industry. The medication is currently set to help treat seizures in two rare forms of epilepsy that mostly affect children. The medication does reportedly have an increased risk in liver injury, but this seems to be extremely minimal.

The staff at the FDA have been showing their commitment to making this drug pass through their rigorous testing which is unusual for the agency. The staff stated that “the risk-benefit profile established by the data in the application appears to support approval of cannabidiol.” After this announcement was made, the GW Pharma American depositary receipts rose by as much as 4.5% to $126 during the early part of the trading day.

The drug is manufactured from the marijuana plant, and specially the component known as cannabidiol or CBD. CBD has been researched heavily over the past few years and continues to show promise in treating a wide variety of different diseases across the board. The chemical CBD is also very different from that of THC, the main psychoactive component in the cannabis plant. Unlike THC, CBD does not get the user high, which continues to help its efficacy as a treatment for children.

The treatment is known as Epidiolex, and has been around for quite some time, but only recently has this amount of support been shown for the drug by the FDA. Justin Gover, the CEO of the company stated that the drug is made from a cannabis plant that is bred specifically for the medicine to have the highest CBD content with a low THC content. The chemical is then purified and made into a strawberry-flavored oral solution. If approval of the drug is made, it would not only help the whole of the medicinal industry on cannabis, but it would be a giant leap forward in the notion of cannabis. He stated that “epidiolex, if approved, will mark a sea change in the acceptability of cannabinoids as therapy.”

Continue reading
0 Comments

MassRoots Inc (MSRT) Files SEC Paperwork For Cannabis Industry-Focused Cryptocurrency

MassRoots Files SEC Paperwork For Cannabis Industry-Focused CryptocurrencyIn an attempt to separate itself from the crowd and pivot toward a more profitable business model, cannabis media company MassRoots Inc (OTC: MSRT) has filed with the SEC to introduce a cryptocurrency. 

The digital currency is “aimed at encouraging key behaviors within the MassRoots platform, such as high-quality reviews of cannabis strains, which management believes will incentivize user growth and stimulate our platform’s overall activity,” according to the Denver-based company.

MassRoots expects the digital currency to be used by legal cannabis businesses to transact and create customer loyalty programs, among other uses.

Related Link: Florida Rep. Carlos Smith On How His LGBTQ Identity Led Him To Cannabis, Gun Control Advocacy

ICOs: The Difference Between Securities, Utilities 

As the SEC filing warns, there are no assurances that MassRoots will be “successful in developing blockchain-based solutions, that such solutions will be economically viable or that such solutions will be able to generate any revenue.”

Continue reading
0 Comments

Senate Works to Legalize Industrial Hemp Nationwide

A new piece of legislation that would allow hemp to be legalized as an agricultural product is making its way through the Senate right now.

The bill was introduced to the Senate last week by the majority leader Mitch McConnell. After its introduction, the bill was quickly placed on the Senate calendar for Monday, April 16th. After the bill was introduced, something known as Rule 14 was put in place. This rule is a procedural move that effectively allows a bill to skip over the committee process so that it can quickly be brought to the Senate floor. Rule 14 does not by any means guarantee that it will be voted upon, but it is a way to get something fast-tracked through what can sometimes be a long process.

The bill in question is known as the Hemp Farming Act of 2018. The act would allow the legalization of hemp, which until this point has been put on a list of controlled substances. Hemp would then be allowed to be sold as an agricultural commodity, which can then be used for a wide variety of products and goods.

McConnell recently stated that “By legalizing hemp and empowering states to conduct their own oversight plans, we can give the hemp industry the tools necessary to create jobs and new opportunities for farmers and manufacturers around the county.” Hemp has a large range of uses in everything from clothing to industrial uses and beyond. The new bill would effectively allow states to regulate the legality of hemp as well as giving researchers grants to study the plant in greater detail. While there are still many issues in the world of legalization for hemp and the cannabis plant separately, this move represents a step forward in breaking the mold of legalization.

The post Senate Works to Legalize Industrial Hemp Nationwide appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

Marijuana Stocks Newsletter – Good Morning & Happy Tuesday! – April 17, 2018

Will The Latest News From The US Government See Leafbuyer (LBUY) Pushing New Highs Ever since picking back up on LeafBuyer (LBUY), we’ve seen this do something it hasn’t done since December & the big news from last week (more below) could have a lasting impact heading into this week. In mid December, LBUY climbed for several days, saw a brief pull-back and then ran as high as $3.15. Over the last few week we’ve seen a similar trend of a multi-day move up starting on March 29, a slight pullback around April 9th and then a new volume surge that seems to have triggered a monster breakout as of Friday afternoon (4-13). In fact since picking back up on this “Priceline of Pot,” LBUY has rallied by 50%! Are new highs coming today?See For Yourself

Wall Street’s Introduction to CannabisAlthough the legality of cannabis on a national level continues to puzzle many around the country, the industry has not skipped a beat in terms of growth. With many businesses working to get their foot in the door, it seems like Wall Street may be the next big player to get into the cannabis market.Read The Full Article Here

How to Buy Marijuana Stocks?This is one of the most common questions I hear within the investor and trader communities. Almost seems like they don’t know how to ask the question more direct, not how but which Cannabis Stocks or Stocks that are related to the Marijuana Industry as a whole.If you want to just buy a Marijuana Stock that is very simple, just obtain an account with most brokers like Etrade, Scottrade, TD Ameritrade etc. find the company you want under the specific Stock Symbol and submit.Read The Full Article Here

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

The post Marijuana Stocks Newsletter – Good Morning & Happy Tuesday! – April 17, 2018 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

  GreenGro Technologies, Inc. (GRNH) Completes Biodynamics Acquisition and Provides Shareholder Update

GreenGro Technologies Completes Biodynamics Acquisition and Provides Shareholder Update

GreenGro Technologies, Inc. (GRNH), an innovative designer and developer of state-of-the-art indoor vertical farms, today announced it has completed its acquisition of an 80% majority interest in Biodynamics, Inc, an Akron, Ohio-based leader in controlled environmental agriculture (CEA), renewable energy and consumer hydroponics.

GreenGro Technologies today also provided an update on a number of previously announced projects, including;

Global Renewable Resources ‘Smart Vertical Farm’ – The Company is pleased to report that the combination of GreenGro Technologies and Biodynamics’ proprietary vertical farm technologies have enabled them to secure a commitment letter from Mastronardi Produce Ltd. for the marketing of its USDA #1 products from the proposed Global Renewable Resources facility.  Global Renewable Resources expects to begin construction of the new ‘Smart Vertical Farm’ upon completion of financing.  The first phase of the GRR project is expected to consist of a 10-acre tomato facility, with the ability to expand up to 30 acres thanks to the technologies and renewable energies the GreenGro and Biodynamics partnership will bring to the table.CannaCulture Project – Biodynamics has received its first purchase contract from CannaCulture, and expects payment by the end of the second quarter.Development of the 4.5-Acre Site for a Canna-Business Park in Adelanto, CA – Greengro Technologies recently announced the submitting of documents to the City of Adelanto for approval of its plan to design and develop one of Southern California’s largest canna-business parks, with GreenGro’s state-of-the-art indoor vertical farm at the epicenter of the complex.

“GreenGro Technologies continues its ascent in the legal cannabis market with the closing of its acquisition of a majority equity position in Biodynamics, Inc.,” said James Haas, Chairman and Chief Executive Office of GreenGro Technologies, Inc. “We are committed to increasing corporate revenues while also expanding via strategic investment opportunities that deliver multiple revenue streams on behalf of our shareholders. In fact, we have promising new bids out for our canna-business park as we speak.  I am confident we will be able to report outstanding growth for 2018 as we continue to increase our market share in an ever-growing marketplace while at the same time solidifying our position as one of the top innovators in our space.”

Mr. Haas went on to say that with all of the projects the Company is involved with currently along with potential new projects coming on board, he anticipates additional shareholder updates in the very near future.

To be added to GreenGro Technologies’ investor lists, please contact Bill Miller at .

Continue reading
0 Comments

Future Farm Technologies Inc. (FFRMF) Strategic Partner BCWC, LLC Selected as One of 20 Applicants to Receive Priority Certification

Future Farm’s Strategic Partner BCWC, LLC Selected as One of 20 Applicants to Receive Priority Certification by the Massachusetts Cannabis Control Commission

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF) is pleased to announce that BCWC, LLC (“BCWC”) has been named as one of 20 recipients of Priority Certification by the Massachusetts Cannabis Control Commission (“CCC”). BCWC’s application to enter the recreational marijuana business will therefore be reviewed on an expedited basis.

As previously announced, Future Farm has entered the Massachusetts cannabis market through its strategic partnership with BCWC, formerly known as Bristol County Wellness Center, Inc. BCWC has a special permit from the City of Attleboro and a provisional license from the Department of Public Health to build and operate a 24,700-sq ft. Registered Marijuana Dispensary (“RMD”) that will grow and sell medical marijuana.  Because of that achievement, BCWC had the right to apply, and did so, to the CCC for “Priority Certification.”  Recipients of Priority Certification are exclusively able to file the first round of applications to, among other things, cultivate marijuana for adult use (i.e. recreational use) beginning on April 16.  The CCC announced on April 10th that, out of well over 200 applications for Priority Certification, it granted only 20.  BCWC was one of the 20 recipients of Priority Certification.

Derek Ross, BCWC’s Manager, commented, “We are very proud to be one of only 20 companies chosen. Becoming a leading cultivator and retailer of adult use cannabis in Massachusetts is a key part of the BCWC strategy. We also look forward to contributing to an increase in the Massachusetts cannabis tourism industry, providing the state with revenue, tax dollars, and job growth.”

Mr. William Gildea, CEO of Future Farm commented, “We made the decision to support BCWC because of the experience and professionalism of Derek Ross and his team. Their success in making this very short list of applicants with Priority Certification demonstrates why that decision was a good one.”  He continued, “This development further solidifies our position as one of the first movers in a state that has approved, but not yet implemented, the adult use of cannabis.”

Future Farm’s strong strategic partnership with BCWC includes loaning BCWC $5,003,100 under a Secured Convertible Promissory Note to fund completion of the 24,700 sq ft vertically integrated BCWC facility in Attleboro, as well as active managerial, administrative and operational support.  The Note will convert automatically into a 51% ownership interest in BCWC on the date on which BCWC receives its RMD Certificate from the Commonwealth of Massachusetts.

Continue reading
0 Comments

How to Buy Marijuana Stocks?

One of the most common questions I hear within the investor and trader communities. Almost seems like they don’t know how to ask the question more direct, not how but which Cannabis Stocks or Stocks that are related to the Marijuana Industry as a whole.If you want to just buy a Marijuana Stock that is very simple, just obtain an account with most brokers like Etrade, Scottrade, TD Ameritrade etc. find the company you want under the specific Stock Symbol and submit.

If you google right now Trending Stocks, I am almost certain one of the listings will be a Stock that is related to the Cannabis or Cannabinoid market.Medical MJ has seen a huge breakthrough in the recent months, and is at the Top of almost every single Investor in the Market Place. With newer and better plant variations being produced almost hourly, this is such a Big Deal, that even the Republicans are starting to become believers of how beneficial Marijuana really is.

Medicinal Cannabis is taking interest, but wait until Marijuana becomes recreational across the country. It does sound scary, but just a matter of time. I know there is a ton of rumors around, that this is the best company they just came out with a new Hot Sauce, or this is the best Cannabis Stock it just distributed a new THC drink. I know we enjoy a good laugh as intelligent investors, but it really does spread a bad rep for the real companies that truly are Undervalued and Emerging as you read this.

What we could focus on more is a well-rounded company that also happens to be publicly traded. A legit Medical Marijuana Stock that handles everything from Growing, selling, edibles even Hemp products. What you are targeting is a company that has the biggest and strongest ability to produce revenues. Keep in mind one thing that never fails to impress is posted Earnings, and as most of us know the more revenue produced the more ability to show Big Earnings Dollars.

Will those Earnings usually related to Marijuana Share Holder Value, but this is not the core thing to fall back on. You also need to make sure the company is in a strategic position to where they can produce the same revenues year after year with steady growth.

Continue reading
0 Comments

Wall Street’s Introduction to Cannabis

Although the legality of cannabis on a national level continues to puzzle many around the country, the industry has not skipped a beat in terms of growth. With many businesses working to get their foot in the door, it seems like Wall Street may be the next big player to get into the cannabis market.

The company Green Table is one of many businesses working to get to the forefront of the cannabis industry. Green Table has been working as a networking business, helping to bring investors together with entrepreneurs in the industry looking to give funding. The industry as a whole has been able to reach as high as $7 billion thus far, with a growth rate of over 29% moving forward. Peter O’ Dowd of Green Table stated that “We are getting great traction. We only launched a year ago. We do it at beautiful locations or in states that are having critical opportunities like, for example, July recreational here in [Massachusetts]. That’s what attracted us here. We have institutional backgrounds in terms of capital markets.” The theme of individuals moving from other, more notable industries continues to fuel the cannabis market with a large amount of qualified individuals.

O’ Dowd further stated that “We’re Wall Street, guys … and we noticed that there was an opportunity in the cannabis marketplace in terms of capital raising at the highest end, at the premium level, where people who have big checks to write — and we’re talking about private equity funds, ultra-high-net-worth individuals.” This opportunity is something that continues to present itself as the whole of the cannabis market moves forward. Throughout the country and beyond, individuals have been flocking to marijuana to try and make businesses out of such a new market. According to O’ Dowd “It is becoming mainstream, and in a lot of circles, especially in financial markets now, it’s a question of when not if. And then that’s overwhelmingly reflected in the way Americans are being polled, and the dollars, the large dollars we are seeing. For example, in private equity, which is strictly related to cannabis, they started out with $5 and $10 million funds. We are now seeing $50 and $100 million funds just a year later coming to market.” These types of large investments are extremely necessary for any of these companies to flourish in an industry where cash matters. O’ Dowd’s company was able to raise as much as $120 million last year for one company in the industry. These large investments also continue to show how devoted the investor base is to cementing this market throughout the country.

O’ Dowd went on to state that “We have packaging companies that are going public, not just in Canada, but also in the United States, that are raising money just for branding and marketing because at the end of the day, this is becoming a consumer product just like your mainstream detergents and laundries and cereals.” The fact that the market is becoming so mainstreamed, and continues to fuel even more investors in the space. O’ Dowd then stated that “this is going to be something that’s going to become a mainstream consumer product in the next several years.” The hopes are high that the combination of investors and individuals who would like to see the marijuana market grow, will continue to build the market of the future. Only time will tell how well these investments can continue to grow the space. With companies like Green Table helping to build the market from an investor standpoint, it seems now that anything within the realm of cannabis is now a possibility.

The post Wall Street’s Introduction to Cannabis appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

Hemp, Inc. (HEMP) Act of 2018 Will Legalize Hemp and Spur New Market Opportunities

Hemp Farming Act of 2018 Will Legalize Hemp and Spur New Market OpportunitiesHemp, Inc. (HEMP) applauds Senate Majority Leader, Mitch McConnell, for introducing a bill last week that would remove industrial hemp from the federal government’s schedule of controlled substances.  The Hemp Farming Act of 2018 stipulates that hemp will be legalized and removed from the Controlled Substances Act and also makes industrial hemp eligible for crop insurance.  As a global leader in the industrial hemp industry with the largest multipurpose industrial hemp processing facility in the western hemisphere, Hemp, Inc. has been a long-time proponent for industrial hemp and sees this as a widespread opportunity for farmers across the country to grow hemp and reap the economic rewards of growing hemp.

“This Hemp Farming Act sends a clear message to U.S. farmers that they should get started planting as much hemp as they can. This bill can be revolutionary. It has already started sending shockwaves through the farming and agriculture communities across the country,” says Bruce Perlowin, CEO of Hemp, Inc. (OTC PINK: HEMP). The filing of The Hemp Farming Act of 2018  follows the Omnibus Spending Bill recently signed by President Donald Trump that includes certain protections for hemp.

Stated in a press release from Senator McConnell’s office, “The Hemp Farming Act of 2018 … builds upon the success we have seen through the hemp pilot programs by allowing states to be the primary regulators of hemp (if the U.S. Department of Agriculture approves their implementation plan). This legislation will also remove the federal barriers in place that have stifled the industry, which will help expand the domestic production of hemp. It will also give hemp researchers the chance to apply for competitive federal grants from the U.S. Department of Agriculture – allowing them to continue their impressive work with the support of federal research dollars.”  To read the full press release from McConnell’s office, click here. McConnell is optimistic that industrial hemp can become, sometime in the future, what tobacco was in Kentucky’s past (according to a recent Forbes article).

Previously, McConnell has helped develop new federal and state legal permissions for hemp and even steered hemp into the 2014 Farm Bill and co-sponsored the Industrial Hemp Farming Act of 2015. Now, McConnell’s new bill will remove industrial hemp from the Controlled Substances Act.

New data show that U.S. hemp production soared in 2017 – signaling that the hemp industry now has more momentum than ever to become America’s newest leading industry. More acceptance for hemp and CBDs, coupled with easing regulations at the state level, are just the right stimuli to cause U.S. hemp production to surge, as we have seen just this past year.  One source noted, “From 2016 to 2017, the number of acres licensed for hemp cultivation in the top 10 hemp-growing states grew by 140% – while the number of hemp producers doubled over the same one-year period.”

There has also been a need in the market to help hemp farmers figure out optimal growing practices.  Hemp, Inc. identified that need a year ago and has since established the Hemp, Inc. University which has, to date, educated over 800 attendees.  “We have seen how the decrease in profitability of tobacco farming has compromised the family farm, leading many to abandon generations-long businesses in search of different employment in more urban settings. We are proud to be on the forefront of the industrial hemp movement and look forward to sharing that experience and expertise,” said Perlowin.

Continue reading
0 Comments

Is the Marijuana Market Heading Up?

With new promises for positive marijuana legislation in the works, it seems as though many are happy with the upcoming state of the cannabis industry. recently, Senator Cory Gardner struck a deal with the president after stalling the president’s nominees for U.S. Department of Justice back in January. The move for the stalling comes after Attorney General Sessions worked toward overturning the Obama era legislation policy that made sure the federal government was not interfering with individual state law. With Gardner’s home state of Colorado helping to lead the fight for marijuana legislation, it seems now that anything is possible.

After blocking nominations for some time, Gardner was finally able to come to a deal with the president. Trump and Gardner decided that the national government would continue to not interfere with individual state law, in regard to prosecuting marijuana-based companies acting within their state laws. Many have stated that this agreement could mean the flourishing of some stocks in the industry but only time will tell.

Back when Trump decided to put Jeff Sessions in place for Attorney General, many in the cannabis industry were scared as to what ramifications this would have for all of the action they had put forward up until this point. Sessions has stood against the use of cannabis for a long time, stating that “good people don’t smoke marijuana.” The move by Sessions to overturn the aforementioned policy was met with a large amount of criticism within the industry, but the new deal has helped to show that the national government will not interfere nearly as much as before.

This news has had a good impact on marijuana stocks, and it continues to look as though the potential for a boost in prices may happen. The deals news helped to light a fire underneath several of the top marijuana stocks in the market as of last week. The largest move in the industry came from Aphria (NASDAQOTH:APHQF) with shares jumping as much as 15%. Many are wondering as to why a Canadian stock would respond so positively to news that only seems to pertain the U.S. The Canadian market is undoubtedly tied with that of the American market. It seems as though both markets have been able to boost each other up, relying on correlation and partnerships to grow the industry as a whole. Many Canadian companies have also begun to set up shop in the U.S. with growing positivity on an individual state level regarding cannabis legislation. Aphria has a large presence within the U.S. because of this, which means that the correlation continues to be high.

Other stocks in the Canadian market were also able to see a boost with the news such as Canopy Growth (NASDAQOTH:TWMJF) and Aurora Cannabis (NASDAQOTH: ACBFF), which rose by 7% and 8% respectively.

Continue reading
0 Comments

Emblem Corp. (EMMBF) Continues to Bolster Professional Leadership Team with Three Strategic Hires to Grow Market Share

Emblem Continues to Bolster Professional Leadership Team with Three Strategic Hires to Grow Market ShareEmblem Corp. (EMC.V) (EMC.WT)(“Emblem” or the “Company”), a leading Canadian integrated cannabis company, is pleased to announce it has appointed Maria Guest as Chief Marketing Officer to its executive team. The Company is also pleased to welcome Kim Horrill as Vice President of Medical Marketing and Tim Andrews as Vice President, Creative Director. The foregoing appointments remain subject to the approval of the TSX Venture Exchange.

Prior to joining Emblem, Maria Guest spent 20 years building brands and developing new products and innovations within the highly regulated and competitive alcohol industry. Ms. Guest most recently led marketing efforts behind iconic brands like Corona, Stella Artois, Bud Light, Michelob Ultra, and Alexander Keith’s. She has also led new product innovations for prominent brands that include Budweiser, Bud Light, and Labatt Blue. Within her extensive portfolio, Ms. Guest spearheaded the successful launch of Bud Light Lime in Canada, as well as introduced Labatt’s first hard cider product to the Canadian market.

Ms. Guest will lead the Company’s adult-use strategy, including the development of unique brands that will speak to various segments of the Canadian adult-use cannabis market. As Chief Marketing Officer, Ms. Guest will leverage her extensive marketing and brand development experience, as well as her understanding of product distribution in a regulated industry to help grow Emblem’s presence across the country.

Kim Horrill brings extensive health care and pharmaceutical experience to Emblem, including working as both a critical care nurse and an acute care nurse practitioner/clinical nurse specialist in pain management. She also spent over a decade with a major Canadian pharmaceutical company in both its Commercial and Medical Sciences Divisions and served as an Assistant Professor at Western University, teaching in the School of Medicine and Nursing. She holds a Master of Science in Nursing from Western University, a Post-Master Acute Care Nurse Practitioner from the University of Toronto, a Post-Master Business Administration from Northwestern University, and remains a member of the College of Nurses of Ontario.

As Vice President of Medical Marketing with Emblem, Ms. Horrill will oversee the Company’s medical outreach program. Along with Emblem’s team of professional medical liaisons, she will educate and engage healthcare professionals across the country on the value of medical cannabis and the benefits of Emblem’s current and future cannabinoid-based pharmaceutical formulations.

Tim Andrews was most recently founder, partner and creative director at Slide Communications. At Slide, Tim provided creative, strategy and design services for clients including Emblem Cannabis, Ayr Farmers Mutual, BridgePoint Financial, Calliope Interpreters, Executive Aviation, Great Lakes Ginseng, Pauwels Travel, and the United Way (Brant & Oakville). Prior to founding Slide, Tim provided creative and strategic leadership through broadcast, print, digital and experiential projects for Labatt, Stella Artois, Sears, Franklin Templeton Funds, The Government of Canada, Burger King, J&J, Clarica and FujiFilm.

Continue reading
0 Comments

Endexx Corporation (EDXC) Announces Joint Venture and Letter of Intent to Acquire Go Green Global Enterprises

Endexx Announces Joint Venture and Letter of Intent to Acquire Go Green Global Enterprises to Expand CBD Brand Internationally

Announcement Comes on the Heels of Former House Speaker John Boehner to Join the Movement in Support of Cannabis Legalization and Bipartisan Legislation Aimed to Advance the Burgeoning Hemp Industry

Endexx Corporation (OTC PINK: EDXC), a provider of innovative phytonutrient-based food and nutritional products, today announced that it has entered into a joint venture and signed a non-binding Letter of Intent (“LOI”) formalizing the acquisition of Go Green Global Enterprises, Inc.  (Go Green).

Go Green currently owns 49.9% of an international distribution company, which will provide Endexx with direct channels of distribution for its CBD Unlimited line of cannabidiol (CBD) Cannsummable Portfolio products including its formulated topical CBD balm and mist, travel sleep aid, teas, oils, capsules, soft chews for dogs and other products that provide key benefits to users. Endexx has collaborated with multiple state regulatory bodies, politicians and the medical community to educate and find compliance and regulatory solutions for both the hemp industry and medical marijuana industry infrastructure.

Todd Davis, Chief Executive Officer of Endexx said, “We are very encouraged by the recent legislative process which include last week’s announcement by Senator Mitch McConnell to legalize hemp under federal law and Former Republican speaker of the House John A. Boehner changing his position on the cannabis industry and its benefits. We believe this is an opportune time to establish our leadership in the global market with the joint venture and LOI for Go Green. We pride ourselves as a leader in education, scientific advancements and the production and distribution of hemp derived CBD products and their benefits.” Additionally, Mr. Davis added, “This venture opens up key international markets including Canada, Europe, South and Central America and the Caribbean provinces. Given Go Green’s location we can strategically manufacture and distribute from a governmentally legalized country.”

Continue reading
0 Comments

Marijuana Stocks Newsletter – Happy Monday – April 16, 2018

Good Morning & Happy Monday! – 4/16/2018!

Can You Say Breakout?:Leafbuyer (LBUY) Pushing The LimitsEver since picking back up on LeafBuyer (LBUY), we’ve seen this do something it hasn’t done since December & the big news from last week (more below) could have a lasting impact heading into this week. In mid December, LBUY climbed for several days, saw a brief pull-back and then ran as high as $3.15. Over the last few week we’ve seen a similar trend of a multi-day move up starting on March 29, a slight pullback around April 9th and then a new volume surge that seems to have triggered a monster breakout as of Friday afternoon (4-13). In fact since picking back up on this “Priceline of Pot” LBUY has rallied by 50%! Are new highs coming today?See For Yourself

Marijuana Stocks are About to Explode – Sorry, Not Sorry Jeff Sessions!Marijuana legalization is occurring around the world! Everyday more and more people & their governments are in favor of legalizing marijuana. Marijuana Stocks have seen a boom over the past several years. This marijuana stocks boom has taken a hit in the last 6-12 months but more and more Americans are pledging their support. This news from just a few days ago could be a trigger for a big move for the sector.Read The Full Article Here

What Is The Current Progression With Marijuana Legislation?The legal marijuana industry has largely been dependent on the progression of new laws over the past few decades. With states taking on the power to create laws in favor of cannabis legalization, it seems as though a new era of legislation has dawned upon us. Legislative measures are continuing to happen throughout the nation at record speed, and the future of the weed industry is following suit.Read The Full Article Here

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
0 Comments

What Is The Current Progression With Marijuana Legislation

The legal marijuana industry has largely been dependent on the progression of new laws over the past few decades. With states taking on the power to create laws in favor of cannabis legalization, it seems as though a new era has dawned upon us. Legislative measures are continuing to happen throughout the nation at record speed, and the future of the weed industry is following suit.

A new deal has officially been made with President Donald Trump and the Colorado Republican Senator Cory Gardner. The deal could potentially help to solve some of the issues with marijuana legislation on the federal level. Back in January when Jeff Sessions the Attorney General, rescinded a piece of Obama Era legislation, Gardner retaliated by holding up the nominations for the Justice Department. This action by Gardner has helped to pressure Sessions into reversing his decision. In the meantime, Gardner and Trump have agreed that the national government will effectively refrain from prosecuting marijuana sellers and those who are legally involved in the industry. Gardner stated in a press release that “President Trump has assured me that he will support a federalism-based legislative solution to fix this states’ rights issue once and for all.”

Thus far, nine states and the District of Columbia have legalized marijuana for recreational use, with many more having laws in place to allow the consumption of medicinal cannabis. Major players in the industry such as California, Colorado and Washington have all been paving the way for the market to continue its exponential growth into the near future.

One of the hardest parts of the current fight for marijuana reform is Attorney General Jeff Sessions. Sessions has promised that he will continue the war on drugs, which has by many peoples standards, failed miserably. The current war on drugs has only led to mass incarceration of individuals who often do not deserve it, as well as a large opioid crisis. Marijuana seems as though it is the last thing to worry about, yet Sessions is continuing to fight against it. If the national government were to allow states to officially decide whether or not they would like to legalize marijuana, it would effectively make it extremely easy for the industry to grow. This would also have a positive effect on the government as they likely could reap some tax benefits from the market itself.

Although Trump has promised from day one of his campaign to ensure that states have the power, he has been the least bit transparent about his plans for the cannabis market. The one thing that remains in the air is how long the deal with Gardner will last. The market has a large chance at progressing, but the issues surrounding the federal stance on cannabis are continuing to halt growth efforts.

Continue reading
0 Comments

Marijuana Stocks are About to Explode – Sorry, Not Sorry Jeff Sessions!

Marijuana legalization is occurring around the world! Everyday more and more people & their governments are in favor of legalizing marijuana. Marijuana Stocks have seen a boom over the past several years. This marijuana stocks boom has taken a hit in the last 6-12 months but more and more Americans are pledging their support.

USA Attorney General Jeff Sessions has delivered blow after blow to the legal marijuana industry. Mr. Session’s comments & initiatives over the past 12 months has been devastating on the marijuana stock market. Now after several months of speculation and what ultimately felt like the beginning of the end for all the progress the United States of America has made on both the federal but more importantly (for now) the state level, this green industry seems to be bouncing back quicker than ever, thanks to President Donald Trump!

image source: MarijuanaStocks.com

Sen. Cory Gardner (R-Colo.) vowed to block every single one of Trump’s nominees to the U.S. Department of Justice (DOJ) in January. Sen. Gardner’s actions came after Jeff Sessions dismantled the President Obama marijuana administration policy that prevented federal law enforcement officials from meddling in states that had legalized marijuana.

On Friday April 13th, 2018 it was announced by the Washington Post that President Trump has promised to support Sen. Cory Gardner & that he’ll support congressional efforts to protect states that have legalized marijuana! (Sorry, not sorry Jeff Sessions)

According to the Washington Post and to further solidify this amazing development Gardner said Trump told him the marijuana industry in Colorado won’t be targeted. White House press secretary Sarah Sanders said Gardner’s statement was accurate and that Trump is “a firm believer” in states’ rights.

Continue reading
0 Comments

Senate Republican Cory Gardner Agrees With Trump on Marijuana Policy

President Trump recently came to an agreement with one of the top Senate Republicans, that they will together push efforts to protect states that have chosen to put legislation for marijuana in place. This agreement comes after several months of arguing between the President and Sen. Cory Gardner, surrounding the Justice Department nominees.

The Republican from Colorado stated back in January that he would work tirelessly to ensure that all DOJ nominations would be blocked. This occurred after Attorney General Jeff Sessions issues a memo following through on his promise to crack down on the cannabis world. Colorado, the home state of Gardner, is one of the first states to make cannabis legal in the country, thus Gardner’s sentiment for legality.

This past Wednesday, President Trump, and Gardner spoke on the phone regarding the memo. Trump stated that despite this memo, the marijuana industry in Gardner’s home state of Colorado would not be targeted. After this phone call occurred, the senator stated that he would back down in his fight against a new nominee. Gardner stated that “Since the campaign, President Trump has consistently supported states’ rights to decide for themselves how best to approach marijuana. Late Wednesday, I received a commitment from the President that the Department of Justice’s rescission of the Cole memo will not impact Colorado’s legal marijuana industry.” The Senator continued to state that “Furthermore, President Trump has assured me that he will support a federalism-based legislative solution to fix this states’ rights issue once and for all. Because of these commitments, I have informed the Administration that I will be lifting my remaining holds on Department of Justice nominees.”

In the near future, only time will tell how true Trump’s promise is to stay out of the way of legal cannabis states. Until then, this appears to be a positive step in the right direction for the world of cannabis and its legality.

The post Senate Republican Cory Gardner Agrees With Trump on Marijuana Policy appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

The Best Cannabis Stocks Trending?

That that is one of the most complex questions I see asked across investor networks, social media streams, there are a few ways we can target for this long hunted answer.First thing you need is a proper Micro Cap Investor Scanner, tuned with the ability to spit out only companies that relate to Marijuana Stocks. You then want to tell it to only show you companies that are fully reporting, and posting good Revenues.

Don’t worry about the Earnings for now; this will be more of something you have to search for once you have a handful of prospected companies. The key points you want to hunt is, does the Best Cannabis Stocks trend in the U.S. or Canada?

Is the company dealing with Hemp, editable, etc. which area are they targeting?What is the current share structure, how much money have they raised through offerings, are there any prop firms helping them. You can also search for the Best Weed Stocks, just to broaden your search results.

I really feel Marijuana related investments are going to see a huge movement in the near term, now that we have seen bitcoin shoot up the last 2 days over 8,100 and the market trying to regain its traction you bet the next sector to see movement is the MJ sector.

Banks releasing earnings today is hurting the market with the DIJA losing over 400 points causing a frenzy panic with a lot of large institutions selling positions. But this may be a scare tactic perhaps to pull the market back some more to force stabilization?

Continue reading
0 Comments

Marijuana Stocks Newsletter – Good Morning & Happy Friday! – 4/13/2018!

Leafbuyer (LBUY): Are New Highs Coming? REMINDER: The last time LBUY saw a multi-day uptrend at these levels it was back in mid December. LBUY climbed for several days, saw a brief pull-back and then ran as high as $3.15. This month, we’ve seen a similar trend of a multi-day move up, a recent and slight pullback along with increased volume and following the recent 2-day pull back, LBUY has started to make another move up on above average volume Thursday afternoon! Could this signal LBUY’s next move?See For Yourself

Marijuana Stocks Continue to Push BoundariesThe index known as the North American Marijuana Index surpassed the growth of many of the stocks throughout the market this past Thursday, as news of the President’s trade war with China hit other industries quite hard. Because of the speculation that often comes into more traditional industries when big news events hit, many investors saw Thursday as quite a negative day for the market. This was not the case with Marijuana. The index managed to gain as much as almost 5% by the end of the day.Read The Full Article Here

The Effect of Cannabis on the Opioid EpidemicSeveral new studies have come out showing the efficacy of marijuana as a treatment for diseases that would otherwise be treated with opioid drugs. The company Arcview Analysts has shown that the market on cannabis could potentially reach as much as $25 billion over the course of the next three years. The main source of this growth is through the continuous string of legislation happening throughout the country and around the world. With legislation going on in Canada to make marijuana recreationally legal by this Summer, the future seems exciting for the cannabis market.Read The Full Article Here

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

The post Marijuana Stocks Newsletter – Good Morning & Happy Friday! – 4/13/2018! appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
0 Comments

Maricann Group Inc. (MRRCF) Announces Definitive Agreement for Haxxon Acquisition

Maricann Group Announces Definitive Agreement for Haxxon Acquisition

Maricann Group Inc. (CSE:MARI) (75M.F) (MRRCF)  (“Maricann” or “the Company”), is pleased to announce it has entered into a definitive agreement with respect to the acquisition of all outstanding shares of Haxxon AG (“Haxxon”).  The acquisition of Haxxon forms a critical element of the Company’s European expansion strategy.  When complete, the acquisition will allow Maricann to enter the Swiss market through Haxxon’s production of feminized high CBD cannabis plants.  Haxxon operates within a 6,000 sq. m. (~64,500 sq. ft.) indoor facility in Regensdorf, Switzerland; an industrial suburb of Zurich, located less than 10 minutes from the airport.

CEO Ben Ward commented: “Maricann will enhance Haxxon’s existing operations by investing 4,800,000 CHF to improve existing cultivation facilities, improving yield, then add extraction and post-processing capabilities to create finished products for inhalation as a tobacco substitute.   These products will comply with both Swiss and European law with THC below 1% for the local market, and THC below 0.2% for the broader European market.”

Chief Scientific Officer Steven Bennett, PhD. stated earlier: “Indoor cultivation of high-quality Cannabis sativa strains (hemp) allows us to optimally control the environment to express and preserve the cannabinoid and terpenoid profiles desired for inhalation, which is not easily achieved with outdoor hemp. The cultivation of high CBD strains requires attention similar to high THC strains. In both cases, the best starting materials are required to make the most effective and sought-after products.”

The transaction is scheduled to close on or about May 15th, 2018, or as soon as possible, subject to regulatory approval and the approval of the holders of the Company’s 9% secured convertible debentures holding 66 2/3% in principal amount of the outstanding debentures being obtained by no later than May 31, 2018. Haxxon is being acquired for CHF 2,000,000 in cash and CHF 6,000,000 in common shares of the Company at the 20-day VWAP ending two trading days before closing.

About Maricann Group Inc.

Continue reading
0 Comments

Aurora Cannabis Inc. (ACBFF) Completes First Ever Private Export of Medical Cannabis to Italy

Aurora Cannabis Completes First Ever Private Export of Medical Cannabis to Italy

Aurora Cannabis Inc. (“Aurora“) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) today announced the successful delivery of the first ever batch of privately exported medical cannabis from Canada to the Italian government through its wholly-owned German subsidiary Pedanios GmbH. Following the successful delivery, the products have now been distributed to Italian Pharmacies.

Today’s announcement follows the company’s press release of January 18, 2018 , which announced that Aurora and Pedanios had won a highly-competitive EU-wide public tender to supply 100kg of medical cannabis to the Italian government through the Italian Ministry of Defense, who oversee medical cannabis production and distribution in Italy .

“The Italian government has entrusted Aurora as the only direct, foreign non-government supplier to the Department of Defense in response to its first ever public tender to help support the growing demand on its strictly-regulated medical cannabis program,” said Terry Booth , CEO. “We take this responsibility very seriously, and will be supporting the growing number of patients in the Italian system with high-quality products, as well as educational support initiatives for both the general public and physicians.  The Aurora Standard reflects a level of professionalism, product quality and patient care that is increasingly recognized by a growing number of international governments, physicians, pharmacies and patients.”

Aurora’s Chief Global Business Development Officer, Neil Belot , added, “We are extremely proud to become the first non-government supplier to the Italian market. This historic first shipment of premium quality, EU GMP-certified medical cannabis provides Aurora with a first and highly visible foothold in a market with over 60 million people. With nation-wide coverage in place for the cost of cannabis, we anticipate rapid growth, and look forward to establishing the Aurora Standard as the benchmark in this exciting market.”

About Aurora

Continue reading
0 Comments

Marijuana Stocks Continue to Push Boundaries

The index known as the North American Marijuana Index surpassed the growth of many of the stocks throughout the market this past Thursday, as news of the President’s trade war with China hit other industries quite hard. Because of the speculation that often comes into more traditional industries when big news events hit, many investors saw Thursday as quite a negative day for the market. This was not the case with Marijuana. The index managed to gain as much as almost 5% by the end of the day.

Other indexes such as the United States Marijuana Index climbed by as much as 5% as well with the Canadian index climbing around 4%. Trump has stated that China “has repeatedly engaged in practices to unfairly obtain America’s intellectual property.” Because of this news, many stocks went spiraling. The continuous rain on tariffs has in the past also caused an uproar in the stock market, creating wild swings throughout the past several months. Richard Falkenhall, senior currency strategist at SEB stated that “Any escalation in the trade war rhetoric would be more negative for China than the U.S. given the former’s relative dependency on trade, but for now, the markets are focused on the payrolls data.”

The stocks that benefited the most in the cannabis industry were Canopy Growth Corporation (TSX: WEED), with announcements of new developments in terms of acquisitions for the company. The CEO of Canopy recently stated that “This new partnership represents further validation that Canopy is the platform of choice in the cannabis sector. Canopy has an unmatched ability to collaborate with partners given our breadth of operational knowledge, technology, investment capital, and cultivation expertise.” The rest of the market has also been able to benefit from this partnership. Through joint innovation throughout such a small market currently, it seems as though the whole of the marijuana industry can benefit.

Another stock that was able to benefit in the market recently is that of Horizons Marijuana Life Sciences ETF (HMMJ.TO). The stock was able to rise as much as 5%, to close the day out above $15. The ETF, Evolve Marijuana (SEED) was also able to rise by around 5% by the end of the day.

One of the most exciting advancements throughout the market is the partnership between Constellation Brands (STZ) and Canopy Growth. The two have been working to partner up to produce new stores and distribution methods as Constellation has one of the largest distribution businesses for beer, wine, and spirits in the world. This deal at first may have shocked some, but as we move deeper into 2018, it seems as though the deal is only getting bigger. The deal has also sparked the notion that many other companies in the larger blue chip sector, are working to get involved in the lucrative industry that is cannabis. Through this, the list of stocks for the marijuana market has continued to grow by a large amount.

Continue reading
0 Comments

The Effect of Cannabis on the Opioid Epidemic

Several new studies have come out showing the efficacy of marijuana as a treatment for diseases that would otherwise be treated with opioid drugs. The company Arcview Analysts has shown that the market on cannabis could potentially reach as much as $25 billion over the course of the next three years. The main source of this growth is through the continuous string of legislation happening throughout the country and around the world. With legislation going on in Canada to make marijuana recreationally legal by this Summer, the future seems exciting for the cannabis market.

The opioid epidemic has been a large issue throughout the U.S. for quite some time now, but only recently has it helped to change the opinion of many in the states who had negative ideas about marijuana. The approval rate for marijuana use throughout the U.S. is currently at over two-thirds, which is incredible considering it was only around one-quarter around 10 years ago. As a result of this, around 29 states have put in some sort of legislative measures either legalizing cannabis for recreational or medicinal use. Because of this widespread acceptance of the substance and given the state of the opioid crisis, many doctors and scientists have been advocating for the use of cannabis over opioid related drugs.

Two new studies published in various medical journals have shown that the use of recreational pot has had a massive effect on the reduction of opioid use throughout the country. The world of opioid use in the states is extremely disheartening, showing that around 29% percent of patients given opioids for treatment, end up abusing the drug. From those, around 12% have developed some sort of addiction to the substance. These numbers help to illustrate how important this crisis is to the modern day and the effect that cannabis could have on solving it.

Researchers in the two aforementioned studies have shown that the access to recreational cannabis may have a direct correlation with the amount of opioids consumed. The first study shows that there is a 14% drop in states that have access to recreational cannabis for those who use opioids. This represents a 1.8 million-dose drop in those states, helping to show how important this medicine really is. The second study examined opioid prescription data from Medicaid between a five year period from 2011 on. The study shows that there is a 5.88% reaction in the use of opioid prescriptions in states that have laws in place for the use of medicinal pot. For states that offer the use of recreational cannabis, there is an almost 7% reduction in the prescription of opioids. These numbers are quite remarkable considering how long legal cannabis has been around. If the industry is able to continue from a legal perspective, it may help to slow down if not put an end to much of the opioid use throughout the country.

Although both of these studies have found a correlation, they are not fully completed given that there are many other factors that go into the addiction and subsequent use of these drugs. The legalization of cannabis throughout the country is essentially a key factor in seeing how large this effect may be throughout the U.S. If more states are able to put in legislation for the use of legal cannabis, it could trigger a larger correlation between the use of opioids and cannabis. The hopes are high that throughout the next coming years, scientists will continue to be able to see how marijuana use has a large range of benefits including the one mentioned prior.

Continue reading
0 Comments

Marijuana Stocks Newsletter – Happy Thursday April 12, 2018

Good Morning & Happy Thursday! – 4/12/2018!

What’s Next For Leafbuyer (LBUY)? The last time LBUY saw a multi-day uptrend at these levels it was back in mid December. LBUY climbed for several days, saw a brief pull-back and then ran as high as $3.15. This month, we’ve seen a similar trend of a multi-day move up, a recent and slight pullback along with increased volume and yesterday was the first green day to follow the 2-day pull back. Could this be the marker for LBUY’s next move?See For Yourself

Cannabis Advertising in the California MarketAs marijuana becomes more poplar than ever given the current state of legislation in and around the country, many are wondering what advertising will look like for this new market. In states that have legislation put forward for the world of cannabis, many companies have still managed to have a difficult time in advertising their products.Read The Full Article Here

The Future of Branding Cannabis CompaniesIt as if marijuana has taken over the U.S. by storm as over half of the states now have some sort of legal framework for the plant. With more states expected to get in on all the action, it seems as though the world of cannabis marketing is growing at an immense pace as well. A new study has shown that as many as 55% more design projects have been made for new brands in the marijuana industry over the past year.Read The Full Article Here

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
0 Comments

Tetra Bio-Pharma (TBPMF) Clinical Study on Cannabis Oil Capsules for Patients Suffering from Chronic Pain should be completed by Fall 2018

OTTAWA, ONTARIO–(Marketwired – Apr 12, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP) (TBPMF), provides a status report on its encapsulated cannabis oils (PPP005) clinical trials and that these cannabis products are ready to commercialize in the retail market post-legalization.

Natural health products and OTC medications

The authorization from the Office of Controlled Substances marks the initiation of the treatment phase of the Phase 2 clinical trial that will be used to support Product License Applications post legalization. Tetra is performing this clinical study to obtain safety and efficacy data to support modern claims for the use of encapsulated cannabis oils in the treatment of chronic pain. Tetra’s program is designed to build a leading position in the development and commercialization of cannabis-based natural health products. Tetra’s products are being developed to be compliant with standards expected for pharmaceutical products which will be supported by scientific and clinical evidence.

PPP005 Phase 1 Clinical trial

Phase 1 clinical trial to assess safety, tolerability and pharmacokinetics of single and multiple dose of encapsulated cannabis oil (10 mg THC with 10 mg CBD) will be completed soon. “This study will provide cardiovascular safety data to ensure that the oil formulations can be safely used by consumers. The pharmacokinetic data will provide the data required to define the frequency of dosing needed to avoid inappropriate use that could lead to accumulation of cannabinoids in the body,” said Dr. Guy Chamberland, M.Sc., Ph.D., interim CEO and Chief Scientific Officer.

Continue reading
0 Comments

Plandai Biotechnology (PLPL) Provides Update on its Convertible Debt

Previously Issued Convertible Notes Now in Friendly Shareholder Hands

LONDON, UNITED KINGDOM, April 12, 2018 (GLOBE NEWSWIRE) — Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to provide an update on the status of previously issued convertible notes.

Over the past several months, management has been actively pursuing the resolution of various outstanding convertible notes. Because of these efforts, most of the convertible notes are cancelled or now held by friendly shareholders of the company. The conversion of the balance of these notes could have resulted in material dilution to the Company’s shareholders and potentially a significant decrease in the price of the common stock.

Callum Cottrell-Duffield, Chief Operating Officer of Plandai, commented, “One of our biggest objectives has been the restructuring of our debt. To this end, we have been working tirelessly behind the scenes to minimize our operating expenses, so we can avoid taking on new debt while simultaneously looking for a partner to assist in the cleanup of our financial situation as we look to become SEC compliant and fully-reporting in 2018. Having now restructured the majority of our convertible debt, we felt our shareholder base should be aware of our progress.”

About Plandai Biotechnology, Inc.

Continue reading
0 Comments

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting

LONDON, April 12, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, today announced that the Company will present data from the pivotal Phase 3 trials of Epidiolex® (cannabidiol oral solution) in Lennox-Gastaut syndrome (LGS) and Dravet syndrome, along with other supportive data, at the American Academy of Neurology (AAN) Annual Meeting, April 21-27, 2018, in Los Angeles, California.

Highlights of the data to be presented include:

Long-term safety and efficacy data in patients with LGS and Dravet syndromeSafety and efficacy outcomes by time in Phase 3 LGS studiesExposure-response analysis in Phase 3 LGS studiesResults from a study evaluating the abuse potential of purified cannabidiol oral solutionAnalyses of the direct cost burden associated with LGS and Dravet syndrome in the U.S.“We look forward to sharing additional findings from our Epidiolex clinical program with the broader neurology community at AAN and expect that the significant continued flow of data should be supportive for neurologists as they grow their understanding of our medicine,” said Justin Gover, GW’s Chief Executive Officer. “With regulatory applications for Epidiolex accepted for review in both the U.S. and Europe, and an expected U.S. launch in the second half of this year, this is a very exciting time for our Company and those awaiting this new potential treatment option.”

Sunday, April 22, 2018Poster Session P111:30 a.m. – 5:30 p.m. PT

Poster 264: Long-term Safety and Efficacy of Cannabidiol Oral Solution in Patients with Lennox-Gastaut Syndrome (LGS): Results from Open-label Extension Trial (GWPCARE5)Poster 271: Exposure-Response Analysis of Cannabidiol Oral Solution for the Treatment of Lennox–Gastaut SyndromePoster 266: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Abuse Potential of Purified Cannabidiol Oral Solution in Subjects with a History of Recreational Polydrug UseMonday, April 23Session S19: Epilepsy/Clinical Neurophysiology (EEG) II3:30 p.m. – 5:30 p.m. PT

Continue reading
0 Comments

What’s the Best Marijuana Stocks in 2018?

Will let’s look at a few facts first before diving into this Trending topic:Marijuana has seen real scientific breakthroughs in the last 2 years.More states are moving towards legalization very firmly for both Medical and Recreational Marijuana.Taxes and regulations on Cannabis still seem to be consistent, without any huge fluctuations.

Sense the True Marijuana Taboo has been finally digested; we have seen more companies jump into the Cannabis market. Medical Marijuana medications are seeing breakthroughs on a huge scale, treating a more complex list of sickness and conditions by the hour.So now not only is Marijuana accepted across the masses, but the science behind the drugs impresses us over and over.

In fact it is so impressive, studies have predicted Marijuana Legalization possibly has a relation with decreased prescription opioid use and death related overdose.Legal Marijuana is seeing juggernaut sales growth, near 35 percent just in 2017. What can we see in 2018, what if I told you the projections are winking at ridiculous numbers maybe something crazy like another 35 percent? I am going to leave that research up to you, what I can tell you is we have a pretty good ability to benefit from these projections.This is the exact reason we keep seeing new and existing publicly traded companies dive into the Marijuana Space.

Keep in mind this booming Marijuana movement is very similar to the Prohibition. You know the times when Alcohol was not legal under federal law. Will look at it now, a multi gigantic industry that just keeps pumping out money, now do you see why I / We are so eager about the direction this new Industry is taking?

Marijuana penny stocks have kept pace and still very much popular, I see more and more investors by the truck load jumping head first into these companies. It really is a Huge Booming Sector, even today. Keep in mind this has been going on for the past 8 years now, and Still very Hot and Active.

Continue reading
0 Comments

Medical Marijuana, Inc. (MJNA) Subsidiary Kannaway® to Host Largest National Convention in Company History

Medical Marijuana, Inc. Subsidiary Kannaway® to Host Largest National Convention in Company History

Medical Marijuana, Inc. (MJNA) announced today that its subsidiary Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding its Empower National Conventionfrom April 14-15 in Las Vegas, Nevada. This event will be the largest event in the company’s history.

Attendees will have the opportunity to learn first-hand about company developments, experience its new products and programs, and celebrate Kannaway®’s impressive growth with fellow Brand Ambassadors from around the world.

“We are excited to celebrate the achievements of Kannaway since last year’s national convention event,” said Kannaway® CEO Blake Schroeder. “Kannaway has grown nearly 40X in just two years and this convention is a perfect opportunity to bring together the team from across the globe and continue that momentum in 2018.”

Attendees will hear from executive team members, including Kannaway® CEO Blake Schroeder, President Brad Tayles and CEO of Kannaway® parent company, Medical Marijuana, Inc., Dr. Stuart Titus. Additionally, the event will also feature more than a dozen guest speakers including CBD advocates, Kannaway executives, and top-ranking Brand Ambassadors.

Continue reading
0 Comments

Marijuana Stocks – Good Morning & Happy Hump Day! – April 11, 2018

Good Morning & Happy Hump Day! – 4/11/2018!

Leafbuyer (LBUY) Could Be Gearing Up For Another RallyLBUY has seen a strong move over the last few weeks and the recent price action could be signaling the next move. Late Tuesday (4-10) LBUY bounced off a previous support on strong volume to close at $1.44. The last time LBUY saw a multi-day uptrend at these levels it was back in mid December. LBUY climbed for several days, saw a brief pull-back and then ran as high as $3.15. This month, we’ve seen a similar trend of a multi-day move up, a recent and slight pullback along with increased volume. Could This Signal The Next Big Move For LBUY?See Why LBUY Is Being Called A Gamechanger

The Cannabis Market is Just Getting StartedThe past several years have seen a boom in the cannabis industry with positive legislation happening around the country. Many have stated that the market and how it currently stands, has many similarities to the Gold Rush of 1849 back in California. But this could be just the beginning.

Read The Full Article Here

Who is Making Millions From Marijuana Stocks?With all this crazy talk about Marijuana, Do you ever wonder what all the fuss is about?I mean besides the fact that this is the Brand new Multi-Billion dollar Industry of our generation, remember when the Rockefeller’s (Tycoon of Oil Industry), or the Carnegie’s (Tycoon of the Steel Industry) moved into very powerful positions in their times. Are we about to see a power house rise up in the Marijuana Industry?

Continue reading
0 Comments

Emblem Corp. (EMMBF) Signs 3-Year Supplier Agreement with Fire & Flower

Emblem Signs 3-Year Supplier Agreement with Fire & Flower

Emblem Corp. (EMC.V) (EMC-WT.V) (“Emblem” or the “Company”), announced today that it has entered into a supplier agreement (the “Agreement”) pursuant to which Emblem, through its wholly owned subsidiary, Emblem Cannabis Corp., will become a preferred cannabis supplier to Fire & Flower Inc. (“Fire & Flower”).

Subject to the approval and subsequent Royal Assent of Bill C-45, the proposed Cannabis Act (Canada) and the receipt by Fire & Flower of all required licensing under the applicable provincial cannabis regimes, pursuant to the Agreement, Emblem will supply Fire & Flower with Emblem branded cannabis products for an initial period of three consecutive years.  It is expected the products will be sold in-store in all provinces in which Fire & Flower operates and, if applicable, in which Emblem has received a provincial listing.

Nick Dean, CEO of Emblem, says the deal presents an incredible opportunity for Emblem to get their adult-use brands into the hands of consumers across Canada. “The retail environment will be critical to generating brand awareness, educating the consumer about products and ultimately driving market share for our adult-use brands,” says Dean. “Today’s deal with Fire & Flower reinforces our belief that the greatest shareholder value will be achieved in the long-run via channels that give the greatest access to consumers. As Fire & Flower is building a leading retail concept in the cannabis space, we anticipate that this arrangement will assist us in our single-minded focus on driving shareholder value.”

“We are excited to enter into this agreement with Emblem. Their awareness of the importance of the retail channel in cannabis as well as their commitment to creating adult-use brands that resonate with consumers aligns well with Fire & Flower’s best-in-class retail cannabis strategy,” explains Trevor Fencott, CEO of Fire & Flower. “There is a lot to accomplish preparing for legalization in Canada, and having partners like Emblem that can move as quickly and decisively as us in the space is definitely an asset.”

Certain directors and officers of Emblem have interests in Fire & Flower. In particular, Harvey Shapiro, a director and the Chairman of the Company, is also a director of Fire & Flower. In addition, Mr. Shapiro owns approximately 19.5% of the common shares of Fire & Flower and controls and directs approximately an additional 65% of the common shares through a voting trust. Further, Maxim Zavet, a director of the Company, owns approximately 4.2% of the common shares of Fire & Flower and Nick Dean, the President and Chief Executive Officer of the Company owns approximately 0.3% of the common shares of Fire & Flower.

Continue reading
0 Comments

Emblem Corp. ( EMMBF) to Present at the 2018 GMP Securities Cannabis Conference

Emblem to Present at the 2018 GMP Securities Cannabis Conference

 Emblem Corp. (EMC.V) (EMC-WT.V)(“Emblem” or the “Company”), announced today that the Company’s management team will attend and present at the GMP Securities 2018 Cannabis Conference being held on April 19, 2018 at the Ritz-Carlton Hotel in Toronto.

Emblem’s management team will also be available for one-on-one meetings at the conference.  Interested investors should contact their GMP Securities representative to arrange a meeting with the Company and for further conference registration information.

About EmblemEmblem Corp., through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals – cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol EMC on the TSX Venture Exchange.

For further information contact:

Ethan KarayannopoulosInvestor RelationsEmblem

Continue reading
0 Comments

International Consolidated Companies, Inc. (INCC) Receives $5 Million Dollar Line of Credit

INCC Receives $5 Million Dollar Line of Creditvia OTC PR WIRE-International Consolidated Companies, Inc. (INCC), is happy to report it has received an institutional offer from the IFG Opportunity Fund LLC for $5 million dollars, subject to INCC becoming fully reporting.  As we execute on our business plan the fund has provided us with 3 additional options for funding.

Home

IFG Opportunity Fund, LLC began in 2004 as a private equity fund created to invest in small growth companies through private investments in public equities, commonly referred to as PIPE’s. IFG provides debt, equity and stockholder loans to micro-cap and small-cap companies.

Because they invest their own capital they are able to be more flexible and competitive in their pricing while other funds may be restricted by their investor participation.

BluDog Products is strategically introducing a water-soluble CBD oil super food and wellness drinks (with an extended release formulation) that are easily absorbed. Using a licensed, patented CBD delivery system, BluDog’s CBD products are an alternative over-the-counter therapeutic option to help relieve post-sports inflammation as well as promote relaxation and well-being. BluDog’s CBD products interact naturally with the body’s anti-inflammatory system without any known side effects.

Continue reading
0 Comments